Sexual disorders (both hyposexuality and sexual dysfunction) are common in people with epilepsy, occurring in up to twothirds of patients. However, characteristically, patients do not spontaneously report these problems. Nocturnal penile tumescence testing suggests that the erectile dysfunction has a neurophysiological component. The aetiology remains uncertain but is likely to be multifactorial, involving neurological, endocrine, iatrogenic, cognitive, psychiatric and psychosocial factors. Epilepsy-related factors include the age of onset/duration of epilepsy along with the seizure type and focus. In addition, seizure frequency might be relevant as successful epilepsy surgery can result in an improvement in sexual functioning despite remaining on anticonvulsant medication. Endocrine changes (raised sex hormone binding globulin and reduced free testosterone) have been reported in men with epilepsy, especially when treated with hepatic-enzyme inducing antiepileptic drugs. Studies have not been performed evaluating anticonvulsants that do not induce hepatic enzymes such as lamotrigine. The association between these endocrine changes and hyposexuality is not known. The relationship between seizures, hormones and anticonvulsant medication in women is explored, focusing on issues such as catamenial epilepsy, the menopause, hormone replacement therapy and the polycystic ovarian syndrome. Suggestions for future research and treatment issues are discussed.
INTRODUCTION
The association between epilepsy and sexual disorders has long been known. Griesinger, in the nineteenth century, observed 'sexual weakness' in the majority of his male 'epileptoid' patients, as well as 'in rare cases long lasting morbid sexual excitement' 1 . Despite this, there is still debate as to the aetiology of the dysfunction and even the extent to which epilepsy increases the risk of sexual disorder 2 .
Sexual disorders associated with epilepsy can be divided into those which are directly related to the seizures (ictal), and those unrelated in time to seizure occurrence (interictal).
Self-mutilation 3 , transvestism 4 , sadomasochism 3 , exhibitionism 3, 5 and fetishism 6 , have been described in association with epilepsy, especially involving the temporal lobes, and may be resolved with cessation of attacks through medical or surgical treatment 7 . Ictal sexual behaviour has been described (especially with partial seizures of frontal, parietal or temporal lobe origin), particularly in women with late-onset epilepsy and right-sided foci 8 . Seizures may also be provoked by 'normal' sexual activity 7 . Hypersexuality (excessive sexual activity which produces no lasting relief or satisfaction) is also occasionally reported 3 . However, the most common sexual dysfunction is the interictal disorder of hyposexuality, which Toone 7 defined as 'a global reduction in sexual interest, awareness and activity'.
It is difficult to define 'normality' in sexual functioning, however information obtained from major studies of adult sexual behaviour and sexuality may be used as a guide. The large (2765 subject) American study 'The Janus Report on Sexual Behavior' revealed that at the time of being assessed, only 1% of men and 3% of women had never had a sexual partner and 5% of men and 11% of women had never masturbated. Overall, more than 69% of men and 65% of women had sexual activity at least weekly 9 .
SEXUAL DYSFUNCTION IN PEOPLE WITH EPILEPSY
Gastaut and Collomb 10 were the first to undertake a detailed but uncontrolled study of sexuality in people with epilepsy (PWE). They described a global hyposexuality in over two-thirds of their patients with temporal lobe epilepsy (TLE). Since then many studies have been performed in men with epilepsy, generating rates of sexual disorder ranging from 22% 11, 12 to 67% 3 (Table 1) .
Toone et al. 13 assessed the sexual functioning of male patients with epilepsy attending their general practitioners. They found that 56% of PWE had had previous sexual intercourse, compared with 98% of controls, with only 43% having sexual activity in the last month, compared with 91% of controls. Also 57% of the men with epilepsy had experienced erectile failure compared with 18% of the control group. Eighteen percent of the patients with epilepsy, but none of the controls, has failed to have spontaneous morning erections in the preceding year.
Fewer studies have focused on sexual dysfunction in women (Table 1) . Ndgegwa et al. 14 compared sexual satisfaction in 14 women with epilepsy and 30 controls, all of whom had a regular heterosexual partner, using the Golombok Rust Inventory of Sexual Satisfaction (GRISS) 15 . They found that women with epilepsy had less frequent sexual activity, more vaginismus and generally less interest in sex. Bergen et al. 16 found 34% of 50 female outpatients attending a tertiary referral centre were hyposexual according to the results of a 20-item survey. Demerdash et al. 17 assessed sexual behaviour in 700 female outpatients with epilepsy. They found psychosexual disorders in 18%, especially with temporal lobe foci (dysfunction, 83%; paraphilias, 16%; and gender identity disorders, 2%). However, they admitted that the commonest paraphilia was 'exhibitionalism' which constituted undressing immediately after a seizure, which was most likely to be a post-ictal automatism/confusional state rather than a genuine paraphilia. Women with sexual disorders had a significantly higher incidence of menstrual irregularities. Interestingly, they found a high rate of sexual prodromes (erotic arousal, 15%; sexual intercourse, 9%; and masturbation in 7%) and suggested that these may generate negative reinforcement leading to anxiety and avoidance behaviour, whenever erotic feelings were experienced. A recent study by Stoffel-Wagner et al. 18 found that a third of women with epilepsy treated with carbamazepine denied having any sexual interest.
Reduced fertility in people with epilepsy has also been described; this is partly associated with lower marriage rates but also lower fertility within marriage 19 . Lindsay et al. 20 reported the outcome of a series of 100 children with TLE, in terms of marital status, sexual activity and fertility. Almost all the female survivors, who were not severely handicapped, married irrespective of age of remission. Men who had remission of their epilepsy by the age of 12 were more likely to marry and be sexually active. The authors also found that the women produced children at a rate three times greater than the men. Dansky et al. 21 however, found that only female patients had a reduction (69%) in the expected number of live-born children. They also found that men married less often than women, thus the men had less children overall. Schupf and Ottman 22 compared the fertility rates in terms of live births per person year of marriage, before and after onset of their idiopathic/cryptogenic epilepsy, with their same-sex siblings. They found reduced fertility rates for both sexes after but not before the onset of their epilepsy. Risk factors for reduced fertility were partial seizures and the development of epilepsy before the age of 10.
Other workers have not found this degree of dysfunction. Jensen et al. 2 compared 86 consecutive outpatients aged between 21 and 54 (mean 38 years) with at least a 2-year history of epilepsy, with a control group, using a multiple-choice 'sexual history form' 23 . The mean duration of epilepsy was 22 years, however 45% had been seizure free for the last year. They excluded patients with other medical or psychiatric disorders including alcohol addiction and learning disability. Seventy-one percent of the men and 81% of the women were married or cohabiting with a sexual partner. Only 8% of men with epilepsy reported sexual dysfunction, compared with 13% of controls. Men with epilepsy experienced sexual desire three to four times a week compared with once a day in the control group. In women with epilepsy, sexual desire was experienced twice a week compared to three to four times a week in the control group and there was no statistical difference in sexual dysfunction between women with or without epilepsy. The low rates of sexual dysfunction revealed in this study may be explained by the absence of psychosocial handicaps experienced by the PWE and their high degree of disease acceptance 2 . Furthermore, two recent studies have not shown a difference in libido and sexual functioning between controls and either women 24 or men 25 with epilepsy who were in stable relationships.
AETIOLOGY OF SEXUAL DYSFUNCTION IN PWE
The sexual disorders associated with epilepsy do not only include reduced desire but also an impairment of function. There is much evidence that there may be a neurophysiological basis to this (rather than just psychogenic). Men with epilepsy have been found to have an increased risk of erectile dysfunction (ED); up to 57% 13 compared with 3-9% in the general population 26 . This can occur in isolation 27, 28 , or in conjunction with hyposexuality 10, 29, 30 . Nocturnal penile tumescence testing can help differentiate whether the erectile dysfunction is of physiological or psychological origin, because if tumescence occurs during rapid eye movement sleep, the ED is likely to be caused by psychological factors. Guldner and Morrell 31 assessed the following patients over at least two nights: six men with TLE and ED, two with TLE and normal sexual function and one man with non-epileptic attack disorder (NEAD) and ED. All the subjects had 'normal sexual desire' (sexual thoughts, desires or behaviour at least monthly). Five of the six patients with TLE and ED had reduced levels of penile rigidity during nocturnal erections but only two had reduced tumescence. Diminished rigidity is known to be associated with difficulty in initiating and maintaining penetration and predicts the absence of spontaneous morning erections, which reliably differentiates between organic and psychogenic erectile impairment. Impaired tumescence is associated with vasogenic ED and impaired rigidity is associated with neurogenic ED 32 . The authors concluded that epilepsy-related ED might have a substantial neurophysiological component 31 . Morrell et al. 33 compared the genital blood flow whilst watching erotic videos in eight men and nine women suffering from TLE with normal controls. They found, in both sexes, a smaller increase in genital blood flow in the patients with epilepsy compared with the controls, despite all subjects rating the videos as 'moderately arousing'. The authors concluded that sexual dysfunction in patients with epilepsy may be attributable to physiologic disruptions in sexual arousal.
There are many theories regarding the aetiology of sexual dysfunction, in particular hyposexuality in people with epilepsy, and several different factors may play a part in an individual patient. In addition, the weighting of each factor may vary between the sexes. A summary of the studies investigating these associations is found in Table 2 .
NEUROLOGICAL
Sexual dysfunction may be caused by a neurological condition that is also responsible for the epilepsy, for example cerebrovascular disorders, dementia or brain injury, especially involving the frontal or temporal lobes 34, 35 . However, many of the epidemiological studies on sexual dysfunction in PWE exclude patients with neurological disorders other than epilepsy 2, 29, 32 , thus limiting the information available about this association.
LEARNING DISABILITY
Fenwick et al. 36 interviewed 97 adult male patients at a centre for epilepsy, of which 80% were below the age of 46. The mean full-scale IQ was 74 (range 34-115). All had chronic epilepsy with a mean age of onset of 6.8 years; 75% had developed epilepsy by the age of 10 and 90% by 15 years. Most patients had partial epilepsy (LRE), with only 9% having primary generalized epilepsy (PGE). Thirty-five percent had never experienced spontaneous penile tumescence on waking and only 21% had it most days. Forty-eight percent had never experienced spontaneous tumescence during the day and only 11% had it most days. Fortyfour percent claimed never to have had an orgasm and 64% claimed not to have had one in the last year and only 21% of the sample admitted to having had sexual intercourse, despite having a sexual partner. At least one-third of those who were sexually active had difficulty in achieving and maintaining an erection. A quarter of the patients were anxious that sexual activity would cause a fit and 8.3% had had a seizure during intercourse or masturbation. They found a positive relationship between having a higher IQ and having had sexual intercourse. Many of the other studies of sexual dysfunction in PWE have excluded patients with learning disability 2, 30 , thus there is limited information about this subject group. However, Gebhard 37 assessed the sexual functioning in men with learning disability but no epilepsy and found that 93% of the population masturbated with an average frequency of once a week to fortnightly and 61% had had sexual intercourse. Thus, low IQ in isolation is unlikely to be a major aetiological factor.
TYPE OF EPILEPSY
The role of the limbic system in sexuality has been demonstrated in animal experiments and depth electrode studies in man. Investigators ablated the temporal lobes in male rhesus monkeys and observed hyper sexuality as part of the Klüver-Bucy syndrome 38 . Bilateral lesions of the corticomedial amygdaloid nuclei in male rats severely impaired (but did not abolish) sexual behaviour 39 and bilateral amygdalectomy in female monkeys produced amenorrhoea and hypogonadal vaginal changes 40 . Feeney et al. 41 reported a sudden cessation in sexual behaviour in four male cats, 1-16 weeks after focal amygdala epileptiform activity had been induced by unilateral aluminum hydroxide injection. There was no change in sexual activity in the cats with induced focal motor epilepsy. Sexual function returned to baseline levels in the three cats that remained healthy, despite ongoing temporal lobe spike activity and the presence of anticonvulsants. The authors suggested that compensation by the healthy contralateral amygdala might have resulted in the improvement in sexual functioning. Focal limbic seizures induced by kindling of the amygdala in the male rat produced an increase in testosterone, oestradiol and prolactin, whereas generalized seizures produced a transient hypogonadal state 42 , suggesting that the sexual and endocrine dysfunction may be associated with temporal lobe seizure activity.
The amygdala has also been shown to have extensive anatomic connections with the arcuate and preoptic nuclei, which are involved in the regulation of gonadotrophin releasing hormone 40 . Heath 43 recorded the EEG of patients during sexual activity and found the septal region to be the main area involved in the orgasm, however, the amygdala, thalamic nuclei and deep cerebellar nuclei were also involved to a lesser extent.
Most studies, but not all 16, 36 have found hyposexuality to be more common in patients with focal (LRE) seizures, especially originating from the temporal lobe. Fenwick et al. 36 found similar rates of sexual dysfunction in patients with LRE and PGE. The study group however was atypical (a residential centre for patients with epilepsy) and only 9% of the sample had PGE.
Gastaut and Collomb 10 were amongst the first to note the association between human sexual dysfunction and focal epilepsy, finding that hyposexuality was more common in patients with seizures originating in the rhinencephalic region.
Waxman and Geschwind 44 described a 'temporal lobe personality'. They noted that hyposexuality occurred in patients with TLE along with deepened emo- 13 ↑ 17 Bergen et al. 16 Murialdo et al. 48 Husain et al.
: association reported; #: no association reported; -: association not investigated; ↓: decreased; ↑: increased; SF: seizure free; FT: free testosterone; PRL: prolactin; Oes: oestradiol; HH: hypogonadotropic hypogonadism; HG: hypergonadotropic hypogonadism; VPA: valproate. tionality, circumstantiality, hypergraphia and hyperreligiosity.
Shukla et al. 30 compared 44 adult patients with TLE with 47 patients with PGE, by interviewing the patient and wherever possible their spouse. They found that over 63% of males and 64% of females with TLE were hyposexual compared with 12% of the men and 8% of the women with generalized epilepsy. The men with hyposexuality reported a global loss of interest in sex, with no erections, nocturnal emissions, fantasies or dreams of a sexual nature and had abandoned sexual intercourse completely. The women only agreed to sexual intercourse after repeated requests from their husbands and did not experience an orgasm. Saunders and Rawson 28 also found hyposexuality to be more common in patients with TLE.
Other researchers have found sexual dysfunction to be more common in patients with LRE whether of temporal or extratemporal lobe origin. Toone and his colleagues 13 compared 54 male patients with epilepsy being treated in the community with a control group of healthy male volunteers. The patients with epilepsy were characterized by low levels of sexual activity and interest as measured by a structured interview. They found no statistical difference between the patients with temporal lobe and non-temporal lobe epilepsy, but found that focal epilepsy (whether temporal or extra-temporal in origin) was associated with more impairment than patients with PGE. Although Murialdo et al. 11 diagnosed sexual dysfunction in 25% of outpatients with PGE and 20% with partial epilepsy, libido was only preserved in the group with generalized epilepsy. Fertility has also been found to be reduced in both men and women with LRE (80% and 85% of the expected rate, respectively), but not in patients with PGE 19 .
Again, less work has focused on women. Herzog et al. 45 found that more than half of 50 women with TLE had some menstrual disturbance. Bilo et al. 46 found six out of 20 women with PGE had menstrual problems (three of these had polycystic ovarian syndrome and two hypothalamic ovarian failure). Isojärvi et al. 47 found a similar rate of menstrual disturbances in women with PGE (21%), partial seizures (18%) and secondary generalized seizures (21%). In a recent study assessing outpatients and members of a regional epilepsy society, women with either LRE or PGE were found to have normal sexual desire but more than one-third had reduced arousability. Women with LRE reported more sexual anxiety, dyspareunia, vaginis-mus, arousal insufficiency and sexual dissatisfaction; whereas women with PGE experienced anorgasmia and sexual dissatisfaction 48 . Cummings et al. 49 found anovulatory cycles to be more common in women with TLE (35.3%), compared with PGE (0%) or controls (8.3%); however the number of patients in the study was small.
Laterality
Several studies, but not all 12, 29, 50 have demonstrated laterality effects in patients with TLE. Herzog et al. found diminished sexual interest in women 45 and sexual dysfunction in men 51 with right-sided TLE. Furthermore, LH pulse frequency was greater in patients with right temporal epileptiform activity or left paroxysmal slowing 51 . Reduction of libido and frequency of sexual intercourse has also been documented to occur more frequently in men following a right compared with left hemisphere stroke 52 . These findings have been corroborated by a recent questionnaire study 53 that revealed a reduction in sexual interest (but not performance) in both men and women with right-sided TLE, compared with patients with left-sided TLE and normal controls.
AGE OF ONSET AND DURATION OF EPILEPSY
Gastaut and Collomb 10 observed that all the patients with childhood-onset epilepsy developed hyposexuality, compared with only two-fifths of those with onset after puberty. They concluded that the occurrence of seizures prior to or during puberty might exert a marked disturbance on the development of sexual attitudes and behaviour.
Taylor 3 found a trend suggesting that early-onset epilepsy limited the chance of marriage. He also observed that subjects whose epilepsy began later in life and who were operated on later had less favourable outcome with respect to sexuality than those with earlier onset and a pathological diagnosis of mesial temporal sclerosis. Lindsay et al. 20 also found men who had remission of their epilepsy by the age of 12 were more likely to marry and be sexually active. Similarly, Shukla et al. 30 found that patients whose epilepsy had started during childhood failed to develop any interest in sexual functioning and those with late-onset epilepsy reported a subsequent decline in both interest and function.
Toone et al. 13 in their community study, found higher levels of gonadotrophins in patients with onset of epilepsy at less than 14 years. Demerdash et al. 17 also found a positive correlation between women with sexual disorders and a longer duration of seizures.
Murialdo et al. 11 however did not find a correlation between patient age or duration of epilepsy and sexual dysfunction and other authors have also found no association 12, 16, 48 , thus the effect of seizures starting before or around the time of puberty remains unclear.
FREQUENCY OF SEIZURES
Some workers have found no correlation between hyposexuality and seizure frequency 10, 12, 36, 48 . Furthermore, a recent study performed by Christianson et al. 54 failed to find differences in sexual functioning (expect for the ability to achieve orgasm) between operated and non-operated patients with epilepsy, despite post-operative seizure control being achieved by 59%. Toone et al. 13 observed similar results in a controlled community study to those found in an outpatient sample 55 , suggesting that the disturbances were unlikely to be dependent on seizure severity or control or other factors which may determine whether the patients were managed by their general practitioners or hospital specialists.
However, some studies appear to reveal an association between severity of epilepsy and sexual dysfunction. Twenty-six percent of the patients in the study by Jensen et al. 2 admitted that their sexual activity had suffered during periods of more frequent seizures and recent studies have confirmed the reduction in libido with increased seizure frequency 24, 53 . Many of the studies documenting significant hyposexuality were in patients seen in a tertiary referral centre or were being assessed for epilepsy surgery 3, 6 and therefore would be expected to have more severe epilepsy. Furthermore, the studies with the lowest reports of sexual dysfunction 2, 11 were performed in patients with high rates of seizure freedom.
Other workers, however, have found an association between improvement in sexual functioning and seizure control attained either with anticonvulsant medication 27 , or following successful temporal lobectomy 6 . Another study 56 found improvement in nonfamily relationships in 56% and in sexuality in 46% of patients who achieved seizure freedom following temporal lobectomy. No patients who continued to experience seizures had an improvement in sexuality.
Taylor 3 evaluated 100 patients with TLE, pre-and post-temporal lobectomy. He found 86 had sexual disorders pre-operatively. Following surgery, 14 remained free of sexual disorders and 22 improved and formed successful heterosexual relationships. Sexual functioning deteriorated post-operatively in 14 men, but this was attributed to increasing age. Improvement in sexuality tended to be seen most in those with greatest seizure relief. Walker and Blumer 57 followed up 50 patients, 2 to 21 years after temporal lobectomy.
Fifty-eight percent were hyposexual before surgery. They found that those individuals with marked or complete relief of seizures had a significant improvement in their sexuality (and in some cases the development of hypersexuality), especially if seizures and spike discharges were completely eliminated by the operation. Those continuing to have seizures rarely showed improvement and may even have deteriorated. The postoperative increase in sexuality occurred despite continued anticonvulsant medication. If seizures recurred the hyposexuality returned.
ENDOCRINE FACTORS
Both seizures and antiepileptic drugs can affect the hypothalamic-pituitary-gonadal axis of males and females and cause changes in hormones and sexuality. These will be considered separately along with an account of normal functioning.
The hypothalamic-pituitary axis in men with epilepsy
The hypothalamus controls production of the steroid hormone testosterone by secreting gonadotrophin releasing hormone (GnRH), which acts on the anterior pituitary gland releasing follicle stimulating hormone (FSH) and bursts of luteinizing hormone (LH). LH stimulates the Leydig cells of the testes to produce testosterone. Only about 2% of testosterone (T) occurs as free testosterone (FT), 43-45% is bound to sex hormone binding globulin (SHBG) and 53-55% is bound to albumin. The testosterone bound to SHBG is not biologically active but the testosterone that is loosely bound to albumin may be available 58 . Fenwick and his colleagues 32 found that patients with low total and free testosterone tended to have diminished sexual activity and reduced nocturnal penile tumescence. The active testosterone is then converted to dihydrotestosterone (DHT) or oestradiol (E 2 ), which can affect sexual desire and functioning. Levels of DHT have been positively correlated with frequency of orgasms in healthy men 59 . The hypothalamus senses the circulating levels of DHT and E 2 , and responds by regulating further production of GnRH. Testosterone and E 2 can also inhibit the pituitary release of LH. FSH acts in the Sertoli cells of the testicles to regulate spermatogenesis. Inhibin produced by the testicles regulates the production of FSH. The incidence of hormone abnormalities seen in hyposexual men without epilepsy vary depending on the clinic to which they are referred (i.e. endocrine, psychiatric, urology), with ranges of 4-28% having low testosterone and 0-8% high prolactin 34 . Hypergonadotropic hypogonadism is a testicular disorder, with low testosterone levels despite high LH input. Hypogonadotropic hypogonadism can be either a primary pituitary disorder with low LH and testosterone or a hypothalamic disorder with decreased GnRH release resulting in low LH and testosterone.
Effect of epileptiform activity and seizures on hormones in men
Herzog and his colleagues 60 assessed 20 men with TLE and found 55% to have reproductive dysfunction or hyposexuality and 45% had endocrine disorders with low FT. Hypogonadotropic hypogonadism was found in 25%, hypergonadotropic hypogonadism in 10% and functional hyperprolactinaemia in 10%. In a later study, they found that LH pulse frequency was more variable in men with TLE than controls 51 .
It is difficult to assess the endocrine effects of seizures alone, and thus interpret the above studies, as most patients with active epilepsy are treated with anticonvulsant medication. Spark and colleagues 61 , however, reported a series of 16 men with no prior diagnosis of epilepsy, referred for investigation of hyposexuality. Eleven of this group were thought to have TLE diagnosed clinically or by EEG and six had neuroendocrine abnormalities (hypogonadism with low testosterone in four and hyperprolactinaemia in two). Anticonvulsant therapy restored both the hormone levels and sexual function in two and the others improved with additional neuroendocrine treatment. The low testosterone may have reduced the seizure threshold in these patients 58 , however, the Spark et al. 61 study has been criticized 62 for using unconvincing clinical criteria including vertigo, fainting and eneuresis for diagnosing epilepsy. A more recent study 50 suggests that seizures per se may be responsible for the endocrine changes observed in PWE. Twenty-two men with medically intractable epilepsy were compared before and after temporal lobe surgery. Serum androgen levels (TT, FT and androstenedione) increased in half of the 14 men who were seizure free post-operatively, despite anticonvulsant medication being maintained. Patients without complete seizure freedom had no significant change in hormone levels.
Studies have shown that seizures may produce transient surges in some pituitary hormones. The hormone prolactin (PRL) is produced by the pituitary gland and has a large variation in baseline levels including surges during sleep with return to daytime levels 60-90 minutes after waking 63 . Serum PRL has been reported to rise within 20 minutes of a spontaneous generalized seizure (GTCS) or one induced using electroconvulsive therapy (ECT) with full neuromuscular relaxation (and thus no muscular activity), contrasting with no change following a non-epileptic at-tack 64 . Others have also found that most patients with generalized [65] [66] [67] [68] and 39-100% with complex partial seizures [67] [68] [69] [70] [71] [72] have rises in serum prolactin, compared with only up to 10% with simple partial seizures 68, 71 . The recent study by Meierkord et al. 73 revealed that complex partial seizures of frontal lobe origin were much less likely to be associated with an elevation of serum prolactin than seizures of temporal lobe origin, although Bauer et al. 68 reported elevations in twothirds of patients having seizures of either frontal or temporal lobe origin. The degree of PRL elevation tends to be greater following GTCS 69, 71, 72 and subsequent seizures are followed by lower rises 70 . There tends to be an 'exhaustion' in prolactin release during status epilepticus 74 . The rise in PRL occurs within 5 minutes of the seizure onset and may remain elevated for 1 hour post-ictally 65, 66 . Prolactin levels do not appear to increase following absence seizures 75 . Interictal PRL levels tend to be normal 70 but some workers have found mildly raised levels in drug free patients 61 , which may be a result of sub-clinical seizures. Hyperprolactinaemia has been associated with sexual dysfunction 34, 76 . Franks et al. 77 reported impotence in men with PRL secreting pituitary tumours and improvement in sexual functioning after treatment with the dopamine agonist, bromocriptine. Studies have also documented that the range of serum prolactin values is greater in patients with right-sided epileptiform discharges 73, 78 , which may account for the increased incidence of hyposexuality observed in some patients with right-sided epilepsy 45, 51, 53 .
An increase in LH accompanying that of PRL has been reported in men following spontaneous generalized seizures 71 and those induced by ECT 79 . In women, both LH and FSH were elevated along with PRL following GTCS 71 . Partial seizures were only associated with an increase in LH in women 71 .
The hypothalamic-pituitary axis in women with epilepsy
The follicular phase begins on the first day of the menstrual cycle, when both gonadotrophin and gonadal steroid levels are low. GnRH is released from the pre-optic and mesial basal nuclei, in response to low circulating levels of oestrogen and progesterone, and promotes the production and secretion of FSH and LH. This surge in release of gonadotrophins precipitates ovulation. The follicle develops into the corpus luteum, which produces progesterone and oestrogen (luteal phase). Progesterone inhibits GnRH and consequently LH. If pregnancy does not occur, atresia of the corpus luteum results in a reduction in oestrogen and progesterone, there is loss of the endometrium and menstruation occurs. The cycle then repeats.
Women with epilepsy have been found to have an increase in menstrual disorders with 25-33% of cycles being reported as anovulatory 18, 80, 81 compared with 10% in women without epilepsy 82 . Herzog et al. 45 found that more than half a group of women with TLE had some menstrual dysfunction including: amenorrhoea (16%), oligomenorrhoea (20%), and an abnormal cycle interval (20%). Two percent had hyperprolactinaemia, and 4% experienced a premature menopause (compared with 1% of the normal population). Twelve percent had hypothalamic amenorrhoea compared with 1.5% of women without epilepsy. Polycystic ovarian syndrome (PCO) was found in 20% (compared with 5% in the general population) and was associated with left-sided interictal EEG abnormalities. Hypogonadotropic hypogonadism was also seen, especially with right-sided discharges. Hyposexuality was also associated with right-sided discharges and low oestrogen levels. Herzog 83 has reported that these menstrual disorders are characterized by inadequate luteal phase cycles (low progesterone during the second half of the menstrual cycle). Menstrual irregularities, PCO and hypothalamic ovarian failure, have also been reported in women with PGE 46 . Elevation of FSH and PRL and a blunting of LH response to GnRH were also found in women with PGE and normal menstrual cycles. Most of the women were taking anticonvulsants (phenobarbitone, valproate or a combination of the two) 46 .
Herzog 40 has postulated that reproductive endocrine disorders in women may result in the development of TLE. He suggested that the anovulatory cycles in PCO and hypogonadotropic hypogonadism might expose temporal lobe limbic structures to oestrogen (which is thought to be pro-convulsant) without the normal progesterone elevation in the luteal phase, and thus promote epileptiform activity. Sharf et al. 84 found that 56.5% of women with anovulatory cycles or amenorrhoea had EEG abnormalities, which normalized in half with the anti-oestrogen drug, clomiphene citrate.
The effect of hormones on seizures in women
Menarche, pregnancy and the menopause can affect seizure frequency in women. Seizures have been reported as starting improving or deteriorating in frequency in all three. However, in most women with epilepsy, these times of major hormonal change have little effect on seizure frequency 83 .
The relationship between changes in seizure frequency and the menstrual cycle (catamenial epilepsy) was first suggested by Locock 85 and Gowers 86 noted exacerbation of seizures peri-menstrually. Since then, catamenial exacerbation has been reported in up to 78% of women [87] [88] [89] , and an increase in paroxysmal EEG discharges has been observed in women with epilepsy around the time of menstruation 90 . However, there has remained controversy as to the existence of catamenial epilepsy, with some workers documenting a peri-menstrual exacerbation in only 12.5% of women 91 and others noting a cyclical pattern in men 92 . In a recent study 93 , 184 women with intractable CPS charted their seizures and the onset of menstruation, for one cycle, during which a mid-luteal progesterone level was obtained. Three patterns of catamenial epilepsy were observed. An exacerbation either peri-menstrually or pre-ovulatory was recorded in 71% of women with ovulatory cycles and 78% of women with anovulatory cycles reported an increase during the second half of the inadequate luteal phase. Using a two-fold cyclical increase in seizures to diagnose catamenial epilepsy, one-third of the women appeared to suffer form the disorder. However, it is difficult to confidently diagnose catamenial epilepsy on the basis of assessment over only one menstrual cycle. Another recent study 94 , assessing 35 women with TLE over an average of four cycles, revealed that half (51.4%) of the women had exclusively ovulatory cycles with 23% having exclusively anovulatory cycles. During ovulatory cycles, the seizure frequency was significantly higher during menstruation compared with the peri-ovulatory or luteal phases. This contrasts with the anovulatory cycles, in which seizure frequency was lower during menstruation.
Various theories for the cause of catamenial epilepsy have been postulated. In animal studies, oestrogen has been found to be pro-convulsant and progesterone, anticonvulsant 95 . Logothetis et al. 96 observed an exacerbation of paroxysmal EEG abnormalities and in some cases clinical seizures, following IV administration of oestrogen to women with catamenial epilepsy. The drug clomiphene acts as an antioestrogen at the hypothalamic and pituitary levels, stimulating gonadotrophin secretion and ovulation, along with normalization of the reproductive cycle 97 . Clomiphene therapy has been shown to reduce seizure frequency in women with partial seizures and menstrual and reproductive disorders (predominantly PCO) 97 . Bäckström et al. 98 observed a reduction in interictal spike frequency in women with partial seizures when a progesterone infusion produced luteal-phase blood levels. Catamenial seizures in ovulatory cycles may be the result of an increase in oestrogen around ovulation or the marked and rapid pre-menstrual decline in progesterone levels, which tends to be more pronounced in ovulatory cycles. Anovulatory cycles are characterized by an inadequate luteal phase (diagnosed by the absence of the usual 10-day increase in body temperature and by a low mid-luteal progesterone level). The resultant raised oestradiol/progesterone ratio may precipitate seizures 40 . The luteal phase increase in progesterone may thus be protective against seizures and the absence of this during anovulatory seizures may result in a generally higher seizure frequency not necessarily menstrually related 94 . These hormonal effects are thought to be mediated via the GABA A and NMDA receptors 99 . Other explanations for these cyclical seizures have been suggested. A fall in phenytoin (PHT) levels has been documented peri-menstrually in women with catamenial epilepsy 88, 100, 101 . However, Bäckström and Jorpes 102 did not find any change in PHT, phenobarbitone (PB) or carbamazepine (CBZ) levels throughout the menstrual cycle. Pre-menstrual tension (PMT) has also been suggested as an aetiological factor. Rosciszewska et al. 88 commented that more women with catamenial epilepsy suffered form pre-menstrual tension and therefore changes in electrolyte and water balance may play a role in the seizure exacerbation, and Crawford 103 commented that stress and anxiety, which are features of PMT, are recognized seizure precipitants.
Progesterone therapy has been used as a treatment for uncontrolled catamenial seizures. Cyclic natural progesterone produced a decline in seizure frequency in almost three-quarters of women with catamenial epilepsy 104 . Synthetic progestogen has also been found to be efficacious [105] [106] [107] , the best response occurring with the depot preparation of medroxyprogesterone acetate. However, caution should be exercised in administering progesterone to women with generalized seizures, as absence seizures may be exacerbated 108, 109 . Recently, it has been shown in a small, uncontrolled study 110 , that seizure control improved when the synthetic gonadotrophin releasing hormone (GnRH) agonist triptorelin (which has a long-term inhibitory effect on gonadotrophin release and suppresses the menstrual hormonal rhythm) was given to women with catamenial epilepsy. Other treatment approaches include the peri-menstrual addition of a benzodiazepine such as clobazam to the treatment regime 111 , or the use of the anticonvulsant acetazolamide, which is a carbonic anhydrase inhibitor and has mild diuretic properties 112 .
Little attention has been paid to the effect of the menopause or hormone replacement therapy (HRT) in women with epilepsy. However, there have been two recent studies addressing this area 113, 114 . The perimenopause is defined as the onset of irregular menstruation accompanied by hot flushes and mood disturbances. During this time the oestrogen : progesterone ratio becomes higher. Harden et al. 114 found that 23% of 39 peri-menopausal women experienced no change in seizure frequency at this time, with 13% experiencing a decrease and 64% an increase. A history of catamenial epilepsy was associated with an increase in seizures. The menopause is defined as the absence of menstruation for at least 1 year, and is accom-panied by a marked reduction in oestrogen production. Menopausal exacerbation of seizures has been reported in 31% of women, and improvement in 41% 114 . Harden et al. 114 also showed that 68% of patients with a history of catamenial seizures reported a menopausal decrease in seizure frequency. Abassi et al. 113 found that 20% of 61 menopausal women related the onset of their seizures to the menopause. However, both these studies were retrospective and further large-scale prospective studies are needed. Very little is known about the effect of HRT in post-menopausal women with epilepsy. There is obvious concern about giving a potentially proconvulsant drug (oestrogen) to a patient with epilepsy. However, the dramatic decline in natural oestrogen, caused by the involution of ovarian follicles during the menopause, should render the risk minimal. In the study by Abbasi et al. 113 three women had been advised against taking HRT by their physicians because of fear of exacerbating seizures. Of the 31 women who had taken HRT, 71% reported no change in seizure frequency, 16% some improvement and 13% worsening. None of the women who were known to be taking progestogen along with the oestrogen suffered a worsening of their seizures and in fact half noted a decrease in seizure frequency. However, Harden et al. 114 found 63% of women receiving HRT (usually combined oestrogen and progestogen) suffered an exacerbation of seizures. Further prospective studies need to be performed in this area, especially in light of the concern that AEDs are associated with bone disorders (osteomalacia, osteoporosis) [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] which may result in bone fractures 125 , which are also more common in post-menopausal women.
ANTICONVULSANT MEDICATION
The relationship between anticonvulsants and hyposexuality has long been known. Bromides were first introduced to treat the hypersexuality that was believed to be associated with epilepsy 85 . However, the actual role that antiepileptic drugs (AEDs) play in the development of sexual dysfunction remains a controversial issue. This review will attempt to address this.
Studies implicating AEDs

Studies conducted in subjects not suffering from epilepsy
A normal volunteer study suggests that AEDs per se may have an effect on reproductive hormones. Connell et al. 126 gave CBZ to subjects without epilepsy and found a rise in SHBG, along with a fall in TT, FT and DHT within 7 days of starting the medication. The hormone levels normalized however, within 3 weeks of continued therapy.
Ejaculatory failure (unaccompanied by ED or a reduction in libido) has also been reported in a man taking CBZ for trigeminal neuralgia 127 and in another taking gabapentin for hypomania 128 . In both cases orgasm and ejaculation returned to normal after withdrawing the AED, suggesting that medication even in the absence of a seizure history may be associated with sexual dysfunction.
Studies evaluating AEDs in PWE
Christiansen and Lund 129 evaluated the effects of AEDs on male hormones and sexual functioning. They found lowered levels of androgens and raised oestrogen, which correlated with reduced potency. Spermatogenesis was also impaired, half the patients had low semen volume, 57% low sperm count, 89% abnormal sperm morphology, 96% low motility and 96% impaired fertility. Since then, few studies have performed semen analysis. However, low volume of seminal fluid has been associated with PHT 130 and valproate (VPA) 131 ; low spermatozoa concentration and count with PHT 130 and VPA 131 ; and inhibited sperm motility (both in vitro and in vivo studies) with PHT, CBZ and VPA 132 . However, Taneja et al. 130 also reported a low volume of seminal fluid, reduced spermatozoa concentration and count in untreated men with epilepsy.
Many other workers have also found hormonal abnormalities in patients taking AEDs (Table 3) . Barragry et al. 133 found elevated TT and SHBG in men with epilepsy treated with the liver-enzyme inducing AEDs: PB, PHT and CBZ. Toone and his colleagues 134 , reported increases in TT, DHT, LH, FSH, SHBG and PRL, along with a decrease in FT in men with epilepsy taking AEDs. Low sexual drive has been found to be associated with a reduction in FT 134 and raised LH 13 . Lower PRL and higher TT and SHBG were reported in patients on polytherapy 55 . These findings have been observed in residential centres 36 , hospital outpatients 135 and community studies 13 .
Most studies have assessed patients on AED polytherapy. Macphee et al. 136 assessed circulating hormones in 41 men with epilepsy on monotherapy (18 taking CBZ, 13 PHT and 10 VPA) and compared them with 12 patients on polytherapy (POLY) and 40 controls, of which 14 were untreated PWE. None of the patients were thought to have had a seizure within the previous 48 hours, although EEG monitoring had not been performed therefore subclinical seizure activity may have occurred. They did not find any significant differences between untreated PWE and the controls without epilepsy, suggesting that epilepsy per se did not affect the hormone profile. Raised SHBG levels 25 were found in patients taking PHT monotherapy and the POLY group. Free testosterone was reduced accompanied by an increase in LH in the CBZ and POLY group. Basal PRL was raised only in the group on CBZ monotherapy. VPA did not appear to affect the level of any measured hormone and the authors suggested that VPA may be a useful AED for male patients reporting sexual dysfunction.
Further support that AEDs effect pituitary responsiveness was provided by Isojärvi et al. 137 , who found lower basal serum LH concentrations in women treated with CBZ and lower basal PRL with a higher response to thyrotropin-releasing hormone (TRH) in male patients treated with CBZ compared with unmedicated PWE.
Dehydroepiandrosterone (DHAS) is an androgen synthesized by the adrenal gland and is not directly under pituitary control. It has been found to be reduced early in the course of CBZ treatment, in both men 138 and women 139 . Macphee et al. 136 also found a marked reduction in DHAS in all groups of patients taking enzyme inducing AEDs (PHT and CBZ), but not in those taking VPA alone. SHBG has been shown to be elevated by treatment with liver-enzyme inducing drugs (primidone, PB, PHT and CBZ), but not VPA or diazepam 140, 141 . However, Lühdorf et al. 142 observed elevated TT in untreated patients on commencing VPA.
Isojärvi et al. 141 assessed the free-androgen index (FAI), which is a measure of non-SHBG-bound testosterone, and found it to be decreased despite normal FT. In a later study, it was found that men who had been taking CBZ and PHT for more than 5 years had raised SHBG and lowered FAI. They prospectively assessed patients beginning CBZ therapy and found testosterone levels remained the same, but SHBG levels increased progressively accompanied by a reduction in FAI, starting in the first year of treatment. They also noted that patients who had been on these drugs for more than 20 years developed sexual dysfunction despite normal libido 143 . Since the levels of SHBG increased progressively over time, this may explain the findings of some workers that sexual dysfunction is more common in men with early age of starting treatment.
Murialdo et al. 11 studied LH pulsatile secretion, gonadotrophin and PRL responses to LHRH in 37 male outpatients with epilepsy, receiving AED monotherapy (PB, PHT or CBZ) who were seizure free. Total testosterone levels were normal, but lower levels of FT and DHT, and higher levels of SHBG were found compared with a control group without epilepsy. There were no significant differences between patients with normal or reduced sexuality, however patients with sexual dysfunction were found to have decreased LH response to LHRH which would be consistent with subclinical hypogonadotropic hypogonadism. Higher oestradiol was also found and the FT/E 2 values were <1 in hyposexual patients and >1 in men with normal sexual function.
Many of the studies assessing endocrine status in PWE have not examined sexual desire and function in the same patients. However, there have been some recent exceptions. Duncan et al. 25 compared 118 treated men with epilepsy, with untreated and normal controls, using the Frenken Sexuality Experience Scales (SES) 144 . They found raised SHBG in patients taking CBZ, PHT and polytherapy. DHAS was lower in patients taking CBZ and PHT monotherapy. They did not find any significant differences in FT and E 2 levels between the study groups, although the mean levels of E 2 in the men taking CBZ or PHT monotherapy were higher than in the controls. In addition, FAI was lower in the CBZ, PHT and polytherapy groups. Untreated patients and those taking VPA did not appear to have significantly different hormone levels than the control group. They found that the men taking AEDs had a stricter sexual morality than controls and were more satisfied with their marriages. They did not find any difference in libido and sexual function between the groups 25 . However, the SES is composed of four sections and only patients in a stable relationship can complete the parts of the questionnaire covering sexual desire and function (including morning erections). Men with reduced libido and/or sexual dysfunction may not have entered into relationships and therefore would have been missed. Stoffel-Wagner et al. 18 assessed sexuality by interviewing 26 men with TLE and comparing their endocrine status with age-matched controls. They found 23% of the men with epilepsy reported erectile or ejaculatory dysfunction, of which three-quarters had low FT levels. In addition, 27% had never experienced spontaneous morning erections. Over a quarter denied any sexual drive, and most of these men also had low FT levels. However, the relationship between testosterone and libido is unclear, as despite finding low FT in over half their sample of male patients treated with CBZ, only a third of them reported a low sex drive. This may be because of denial or additional factors such as oestradiol level (which was normal in their study).
Herzog et al. 145 found raised E 2 levels in men with partial seizures taking PHT. Herzog 146 postulated that hepatic microsomal enzyme inducing AEDs could lower testosterone by inducing SHBG synthesis and by inducing aromatase, which converts testosterone to oestradiol. Oestradiol constitutes only 1% of male gonadal steroids but exerts approximately half of the negative feedback on LH secretion. Suppression of LH results in hypogonadotropic hypogonadism, and chronically low testosterone to testicular failure and hypergonadotropic hypogonadism. Oestradiol can also produce premature ageing of the hypothalamic arcuate nucleus, which may also cause hypogonadotropic hypogonadism, and premature decline of testosterone levels. The decreased T/E 2 ratio stimulates additional SHBG synthesis. Eventually, this could lead to a progressively increasing concentration of SHBG with a progressively declining testosterone level. Since testosterone increases potency and libido, and oestradiol lowers male sexual interest and function, liver-enzyme inducing AEDs could result in a clinically significant sexual dysfunction by the above mechanisms. However, since sexual dysfunction can occur in patients taking non-liver-enzyme inducing AEDs such as gabapentin 31, 128 , other factors must also play a part.
Much less research has been published regarding the endocrine effects of AEDs in women (Table 4). Hepatic microsomal enzyme inducing anticonvulsants increase SHBG (which binds oestrogen) and transcortin (which binds progesterone). Testosterone is 53% bound to albumin and 45% bound to SHBG, oestradiol is 68% bound to albumin and 30% to SHBG, whereas progesterone is 53% bound to albumin and 45% bound to transcortin. Therefore, increases in the transport proteins produced by AEDs will have a greater effect on testosterone and progesterone than oestradiol 140 . Isojärvi 139 found untreated women with epilepsy had higher FT and LH than controls. During CBZ treatment, serum E 2 , progesterone, TT, FT, PRL and FSH concentrations did not change. FAI decreased and SHBG increased after 2 months of treatment and remained altered after 12 months of CBZ. However, the women continued to have ovulatory cycles.
TT has been shown to be increased and the percentage of FT reduced in women with epilepsy 147 , however, others 18, 24 have not found any difference in FT levels between treated women and controls. Raised SHBG has also been reported in women taking anticonvulsants 24 , especially the liver-enzyme inducing drugs, PB 133 , PHT 133, 148 and CBZ 18, 133, 139 .
Duncan et al. 24 assessed the sexual behaviour and attitude of 159 treated and 36 untreated, women with epilepsy, using the SES. They measured SHBG, TT and FT in 88 of the treated patients. They found treated women were more 'moral' and less open to psychosexual stimulation, however the groups differed significantly in their extent of further education which influences the SES scores. Again, the use of the SES may have confounded their results. The study divided subjects into 'treated' and 'untreated', thus the authors were not able to comment on the effect of individual AEDs on sexual function or endocrine status.
Studies disputing the role of AEDs in sexual dysfunction
The hyposexuality noted in two-thirds of Gastaut and Collomb's 10 patients occurred in patients who were SHBG: sex hormone binding globulin; TT: total testosterone; FT: free testosterone; FAI: free androgen index; E 2 : oestrogen; P: progesterone; FSH: follicle stimulating hormone; LH: luteinizing hormone; ↑: increased; ↓: decreased; ↔: as controls; EF: early follicular; F: follicular; L: luteal phase. Sources: Victor et al. 148 ; Barragry et al. 133 ; Isojärvi et al. 47, 139 ; Stoffel-Wagner et al. 18 ; Murialdo et al. 166 not on anticonvulsants and in some, control of seizures with barbiturates or phenytoin led to a return of sexual response.
Hierons and Saunders 27 identified 15 patients with temporal lobe disorders and erectile dysfunction but normal libido. In three, (at least two of which had had a head injury) impotence preceded the development of epilepsy by 6-9 months, during which time no medication was taken.
Half the patients, who were observed to have abnormal LH values and responses to LHRH by Herzog et al. 149 had not been receiving anticonvulsant medication and the others had discontinued medication at least a month before the assessment. In a later study, Herzog and co-workers 60 found sexual dysfunction and low FT in half their sample of men with TLE. They commented that in some patients these abnormalities could not be accounted for by anticonvulsant medication. Taneja et al. 130 found decreased TT and increased LH and FSH along with lower volume of seminal fluid, reduced spermatozoa concentration and count in both untreated men with epilepsy and those taking PHT.
Bergen et al. 16 found no correlation between sexual dysfunction in women and the number or duration of use of AEDs. They also found no difference between patients taking liver-enzyme inducing anticonvulsants and those taking valproate, similarly, other studies 12, 48 have also failed to show a relationship between AEDs and sexual dysfunction.
Furthermore, a recent study 50 found a normalization in the endocrine status of men following successful epilepsy surgery, despite remaining on liver-enzyme inducing medication (CBZ).
MENSTRUAL DISTURBANCES AND THE ASSOCIATION WITH ANTICONVULSANTS
This remains a controversial issue but an area in which much recent interest has been generated.
Valproate has been associated with menstrual disturbances in women with epilepsy since the early 1980s' study by Margraf and Dreifuss 150 , which described eight women who developed amenorrhoea shortly after starting VPA. Six also complained of hyperphagia and weight gain. In seven, however, normal menstruation resumed after 6-20 months without altering the dose of VPA.
Recent work has focused on the polycystic ovarian syndrome (PCOS). Polycystic ovaries (PCO) are diagnosed when there are 10 or more cysts, 2-8 mm in diameter, arranged around an echodense stroma 151 . The polycystic ovarian syndrome is diagnosed when PCO are associated with hyperandrogenism (manifested clinically as hirsutism, acne and male pattern baldness along with raised serum androgens). High serum levels of LH along with low FSH are typically documented 152 . The prevalence of these conditions varies between studies, with ranges of 5-33% being reported [153] [154] [155] [156] , both being more common in obese subjects. The aetiology of PCO is unknown but it may have a genetic, possibly autosomal dominant inheritance. Women with polycystic ovaries may be asymptomatic, but after a gain in weight may develop hirsutism and menstrual cycle disturbance 157 . Obesity and PCO appear to have a separate but synergistic role in the production of insulin resistance 152 . Moreover, the onset of obesity just before or during puberty may be a factor in the subsequent development of PCOS 158 . Insulin resistance results in hyperinsulinaemia. The high levels of insulin act on the liver inhibiting the production of SHBG, thus increasing free testosterone, and on the ovary, stimulating excess ovarian androgen production 157 . The combined effect may result in anovulation and the altered ovarian morphology typical of PCO 158, 159 .
There has been a recent surge of research in this area, much of which has been conducted by Isojärvi et al. in Finland. In 1993, Isojärvi et al. 47 assessed 238 female outpatients with epilepsy. Menstrual disturbances were found in 20% compared with 16% of women without epilepsy. The frequency of menstrual disturbances was not related to seizure type, occurring in 21% of women with PGE, 18% with partial and 21% secondarily generalized seizures. Almost half the women receiving VPA monotherapy had menstrual disturbances, compared with a fifth taking CBZ monotherapy and a quarter receiving a combination of the two AEDs. No women with untreated epilepsy reported menstrual disturbances. Sixty-eight percent of the women taking VPA alone or in combination with CBZ had polycystic ovaries or elevated serum testosterone, however this figure rose to 80% if the VPA was started before the age of 20. TT, FT and DHAS were higher in women taking VPA monotherapy than in controls. Women taking CBZ alone or in combination with VPA had elevated SHBG levels. In a later study, Isojäarvi et al. 160 further evaluated 65 of these women with menstrual disturbances, of which 22 received VPA and 43, CBZ monotherapy. PCO, hyperandrogenism, or both, were found in 64% of the women on VPA monotherapy, 21% of those on CBZ and 19% of controls. Obesity was noted in 59% on VPA, 28% on CBZ and 12% of controls. An indisputable weight gain, (average 21 kg, range 8-49 kg) was found in half the VPA-treated group, 82% of patients who started VPA before the age of 20 but only 18% of the women starting VPA after the age of 20, and almost three-quarters of the VPA-treated patients with PCO/hyperandrogenism. The authors also found that women on long-term VPA, especially those who were obese, were hyperinsulinaemic. The same authors substituted lamotrigine (LTG) for VPA in 12 of the women with PCO or hyperandrogenism and this resulted in a reduction in body mass index (BMI) and reversal of hyperinsulinaemia, accompanied by normalization of elevated testosterone levels. The total number of polycystic ovaries decreased from 20 to 11 after 1 year of LTG treatment and the number of women with bilateral disease decreased from nine to four 161 . The same group 162 investigated the effect of VPA on endocrine function in 41 adolescent girls aged between 8 and 18. Twenty-four suffered PGE, 10, partial and 13, secondarily generalized seizures. Hyperandrogenism was found in 38% of the pre-pubertal, 36% of the pubertal and 57% of the post-pubertal girls. In addition, the post-pubertal girls taking VPA were more obese than controls.
The above studies could be criticized for using ultrasound to diagnose polycystic ovaries, which may be asymptomatic, and for having small numbers of patients in each monotherapy group. In addition, the cases of PCO were combined with those with hyperandrogenism in isolation, for the purposes of analysis, thus it is not possible to determine the actual number of subjects with PCOS. However, case reports from other centres (Damm et al. 163 in Germany and Sharma and Jacobs 164 in the UK) have documented the PCO syndrome in association with VPA.
However, menstrual disturbances have not only been reported in women taking VPA. Herzog et al. 45 found no significant relationship between the occurrence of menstrual disorders and AEDs. Bilo et al. 46 documented menstrual irregularities in women with PGE. Most of the women were taking AEDs (PB, VPA or a combination of the two). No clear relationship with medication was found and three women had developed the menstrual problems before AED treatment was started. Cummings et al. 49 found anovulatory cycles to be more common in patients with TLE, who were mainly treated with polytherapy, especially with CBZ. Women with PGE, who were mainly treated with VPA, had normal ovulatory function. Again, the number of patients in each group was small. Murialdo et al. 165 assessed 101 women with epilepsy in Italy and found menstrual irregularities in 22%, which were independent from epilepsy type and origin of focal discharges. Although PCO were diagnosed in 17% (using transabdominal suprapubic ultrasound), and appeared to be associated with VPA treatment, this rate is similar to that observed in normal population studies. They did however find higher androgen levels, a higher luteal LH/FSH ratio and a lower luteal progesterone surge (suggesting an anovulatory cycle) in VPA treated patients compared with controls 165, 166 . Another recent study 167 has not shown a difference between the incidence of PCOS (defined as hyperandrogenism combined with oligomenorrhoea or amenorrhoea) between untreated PWE and those medicated with VPA or CBZ. Similarly, Betts and Yarrow 168 found, using magnetic resonance imaging, similar rates of PCO in women medicated with either VPA or LTG. However, more women taking VPA had hyperandrogenism suggesting that PCO may be a direct effect of epilepsy per se, but the use of VPA in these patients may result in the development of PCOS.
Although as yet the available information on the development of PCOS in women with epilepsy is limited and conflicting, it is an important area. Menstrual disturbances do occur, and moreover fertility is reduced in these women. The fact that VPA is associated with weight gain is not disputed and the relationship between weight gain around the time of puberty and the subsequent development of PCOS is of concern because VPA is commonly used to treat absence seizures in pre-pubertal girls. Further research is needed in this area and large multicentre studies are currently being performed 169 .
PSYCHIATRIC DISORDERS
Psychiatric disorders, both neurotic and psychotic, are often associated with hyposexuality. One of the cardinal features of clinical depression or anxiety states is reduced libido, and erectile dysfunction is common in patients with alcohol or drug dependence 170, 171 .
Several studies have found a high prevalence of psychiatric morbidity in patients with epilepsy, especially involving the temporal lobes. Pond and Bidwell 172 documented mental problems in 29% of people with epilepsy, rising to 50% in those with TLE. Edeh and Toone 173 found similar results in a community survey (48% were 'psychiatric cases' and patients with TLE had more anxiety and depression). Mendez et al. 174 found 55% of outpatients with epilepsy reported depression.
Medication used to treat psychiatric disorders, including the older neuroleptics and antidepressants, may also impair sexual function in both men and women 175, 176 .
Many studies have either omitted patients with psychiatric disturbance, or have not commented on or assessed their mental health 24, 25 . However, recently, Morrell and Guldner 48 did not find any correlation between sexual disorder and depression in a group of PWE.
PSYCHOSOCIAL FACTORS
Thompson and Oxley 177 examined the psychosocial effects in 92 patients with poorly controlled epilepsy, and found 68% had no personal friends, 34% never formed true friendships, 57% had never had a steady relationship and only 8% were married. Chaplin et al. 178 found that people with epilepsy identified sexual relationships as an area of concern, along with lack of confidence, increased isolation, lack of energy and adverse reactions in their social life and leisure pursuits; all of which could contribute towards the development of hyposexuality. Acceptance of the diagnosis and of acquiring the label 'epileptic', have also been shown to be areas of concern 178 . However, the reaction of the partner may also be relevant. Partners of people with epilepsy may become over-protective resulting in their spouse losing their role as a 'sexual adult' for that of an 'invalid' or 'dependent'. Studies of couples with a diabetic spouse found that only 15% of couples with good disease acceptance, reported sexual dysfunction, compared with 57% of those with moderate or poor disease acceptance 34 . Hermann and Wyler 179 determined the locus of control for patients with epilepsy. Persons who perceive events in their lives as not being attributable to their own efforts but rather to the effects of fate have an external locus of control, whereas those who perceive events as being under their own influence have an internal locus of control. They found that depression was significantly correlated with an external locus of control pre-but not post-operatively. Locus of control may well prove to be a major causal factor in the development of sexual dysfunction in epilepsy. The lack of significant difference in reported sexual dysfunction between operated and non-operated patients described by Christianson et al. 54 may be explained by the similarities in overall life satisfaction in the two groups. A control group had both higher life satisfaction and sexual drive.
Most workers have found that PWE tend to marry less often than normal controls. Dansky et al. 21 evaluated the marriage rate of Canadians with epilepsy, three-quarters of which had developed habitual seizures by the age of 20. They found that 61% of the females and 38% of the males were or had been married, which is 83% and 59% of the expected rate, respectively. Patients (particularly males) with an early onset of epilepsy were less likely to marry and 39% of all patients who married did so prior to the onset of their epilepsy. This confirms the earlier work of Taylor 3 who found that only 34% of his sample was married. Marriage rates may be seen as a measure of desire to enter into relationships in which sexual activity is likely to occur. Monetary difficulties secondary to unemployment, transport difficulties and low self-esteem may also be factors involved in PWE not entering relationships. These factors are likely to influence men more than women. Development of sexual dysfunction would confirm negative thoughts about self-worth and ability to participate in social relationships. Sexual arousal may be negatively re-enforced in patients with peri-ictal sexual sensations or seizures occurring during sexual activity.
TREATMENT OF SEXUAL DYSFUNCTION IN PWE
Sexual dysfunction, whether of physiological or psychological cause may be treatable 34 . However, there have been very few studies conduced in PWE, and all have been performed in men. Daniels et al. 180 found improvement in sexual functioning (increased frequency of morning erections, longer-lasting penile tumescence and greater frequency of reaching orgasm) accompanied by improved seizure control in a placebo-controlled pilot study of intramuscular testosterone. During treatment, LH and FSH levels fell, suggesting that the feedback loop on the anterior pituitary was functioning normally. Herzog 146 also found a moderate improvement in hyposexuality with testosterone, but he concluded that the addition of testosterone alone was not sufficient to produce a marked improvement in sexual functioning because the aromatase induced by the AEDs converted the additional testosterone into oestradiol. He produced improvement in both sexuality and seizure frequency in a man treated with CBZ by adding the aromatase inhibitortestolactone, along with testosterone. However, these two studies involved small numbers of patients and further research is needed in this area.
Sildenafil (Viagra) has been shown to improve both the quality and frequency of erections, regardless of the aetiology (organic or psychogenic), whilst not affecting libido 181 . Although the medication has not been studied in patients with epilepsy, there were no reports of convulsions during the clinical trials. Postmarketing surveillance has detected some reports of convulsions, however in most cases there were other contributing factors such as concurrent use of proconvulsant medication. Sildenafil is metabolized by the cytochrome P450 3A4 enzyme system, therefore concomitant use of liver-enzyme inducing AEDs may speed up its removal (Pfizer, 1999, Personal communication).
Treatment of sexual dysfunction in women with epilepsy is a much-neglected area, and more studies need to be performed.
DISCUSSION
Many of the above studies are flawed, by being retrospective, not using a control group, using nonrepresentative hospital samples and not clearly documenting the seizure type. However, most concur that hyposexuality and endocrine disorders are associated with epilepsy. However, the aetiology remains uncertain, but is likely to be multifactorial in origin involving neurological, endocrine, iatrogenic, psychiatric, cognitive and psychosocial factors. Most studies revealed endocrine abnormalities in both men and women with epilepsy, especially when treated with liver-enzyme inducing anticonvulsants. However, in the majority of these studies, concurrent assessment of desire and functioning has not been performed. Thus the effect of the hormonal abnormalities remains uncertain. The exceptions being the studies by Toone's group 55, 134 in which low drive was correlated with reduced FT. Anticonvulsant medication cannot be the sole cause of the sexual dysfunction, as in some studies the hyposexuality and/or endocrine changes predated starting the AED. Furthermore, in some cases, relief of seizures with surgery resulted in an improvement in sexual functioning despite remaining on medication.
The incidence of sexual dysfunction varies from study to study, however in patients with active epilepsy, rates of hyposexuality appear to be high, even in drug-free patients. It may be that a combination of factors is needed in order for the full spectrum of sexual dysfunction to develop.
It is a striking finding in many studies 3, 29, 30 that patients with epilepsy do not complain of and appear unconcerned about their hyposexuality, especially if their seizures began pre-pubertally. Bergen et al. 16 noted that out of the 17 women in their sample with hyposexuality, only seven had discussed this with a physician. They also commented that only 13% of their entire sample had ever been asked about their sexual function. Reasons for this could include:
(1) If the seizures and sexual disorder began prepubertally, i.e. before the onset of 'normal' sexual desire and function, the patient may not be aware of the dysfunction.
(2) The patient and/or member of the medical profession may not be aware of the association between epilepsy and sexual dysfunction and therefore may not think to explore the topic in the epilepsy clinic.
(3) Sexuality is a subject that may people (both patients and healthcare workers) often find difficult to discuss.
A questionnaire survey of 400 American physicians revealed that only a fifth of responding doctors believed that patients with TLE had a lower libido compared with people without epilepsy and 35% believed that the patients with TLE had a higher libido. The physicians believed that performance anxiety and low self-esteem were the most likely causes of sexual dysfunction in male and female patients with epilepsy, respectively 182 .
However, when patients are asked about sexual function, most appear eager to discuss it and undergo any necessary evaluations and are often relieved to discover that the problem is not unique to them.
Sexual function is an important marker of wellbeing and since patients with epilepsy may not spontaneously complain of dysfunction, physicians and other health care workers should always discuss it when interviewing patients. Bignell 183 has stressed the importance of communication skills in improving the 'sexual health of the nation'.
The effect of epilepsy treatment on sexuality is an important area for research, both to discover more about the aetiology of sexual dysfunction and also to help counsel patients before starting new treatments. Fenwick 184 suggested that determination of sexual functioning should be included in the pre-surgical investigations. This should be combined with a full neuropsychiatric evaluation, including assessment of mental state along with quality of life and locus of control measures. Such studies would help to evaluate the effects on sexual functioning of the different neurosurgical treatments for epilepsy: callosotomy, hemispherectomy, temporal lobectomy, amygdalohippocampectomy and vagus nerve stimulation.
The hormonal actions of the AEDs also need further documentation, evaluating the effects of single drugs on the sexual function and endocrine status of both men and women with epilepsy, taking into account neuropsychiatric factors such as depression and anxiety and controlling for age and circadian rhythms. Since most of the studies on sexuality in epilepsy were performed, many new anticonvulsants have become available in the UK, including vigabatrin, lamotrigine, gabapentin, topiramate and tiagabine. These drugs do not appear to induce the hepatic-microsomal system 185 , therefore evaluation of the effect of these on sexual desire and function, combined with neuroendocrine studies, would be an exciting area of future research. In addition, many of the recognized AEDs, both liver-enzyme inducing (CBZ) and not (VPA, LTG, GBP), are being used more frequently in patients with disorders such as manic depressive psychoses and chronic pain, but without a history of epilepsy. Evaluation of the sexual function and endocrine status of these patients will help to separate the effects of the drugs from the underlying seizure disorder in PWE.
SUMMARY
Seizures, hormones and sexual function have a complex relationship and much is still not understood about the interaction between them. As yet, no definitive study has been performed to determine the incidence of hyposexuality in PWE. There is no doubt that hormonal changes occur which may in part be related to the use of liver-enzyme inducing medication. However, it is not known whether the reported reduction in free testosterone results in hyposexuality. A large, prospective (probably multicentre) study needs to be performed to attempt to determine the effects of epilepsy per se and the individual treatments on sexual functioning and endocrine status, taking into account the psychosocial factors. The lack of available questionnaires covering both sexual desire and function that can be administered to all PWE hinders research in this area. In addition, studies of treatment of sexual dysfunction in PWE are lacking, in particular, no major studies have been performed observing the effects of testosterone replacement therapy.
Much less research has been performed in women, possibly because of the difficulties in taking blood for endocrine studies at the appropriate time in the menstrual cycle; however more research is needed to explore issues such as catamenial epilepsy and the effect of the menopause and hormone replacement therapy.
Much recent interest has been shown in the fertility issues in women, especially in relation to the PCOS. However, hyposexuality and impotence in men is potentially a major source of infertility and this area deserves more attention. The cause of the sexual dysfunction is likely to be multifactorial and it may be that some factors (such as psychosocial and psychiatric disorders) may result in a reduction in libido and others (such as seizures and medication) may be responsible for the endocrine changes and the sexual dysfunction. However, there remains the possibility that the liver-enzyme inducing AEDs may play a major role in the development of these problems, and as there are now many effective alternatives, research studies should focus on this area.
